In the dynamic home health, hospice and personal care industries, scale is sometimes a serious leg up, as well as a driving force behind record-setting M&A activity. That’s especially true when it comes to keeping up with potential Medicare Advantage (MA) opportunities, collecting actionable data and experimenting with new business models that solve nationwide problems, […]
Stoneridge Partners
Cash flow interruptions and operational changes caused by the Patient-Driven Groupings Model (PDGM) may lead to a spike in the number of home health providers in the U.S. filing for bankruptcy, some experts predict. If the forecast is accurate, that may also mean more initial M&A action as well. “I agree with the premise that […]
Home health stocks saw mixed success in February, according to the latest Home Health Index (HHI) from mergers-and-acquisitions advisory firm Stoneridge Partners. The up-and-down February follows a largely positive January. Updated monthly, the HHI by Stoneridge Partners tracks the market values for Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG). Overall, the HHI […]
For the most part, home health stocks performed well in January, with Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG) both seeing double-digit gains. But while Amedisys and LHC Group saw their stock values climb, Addus HomeCare Corporation (Nasdaq: ADUS) saw its stock dip. That’s according to the latest Home Health Index (HHI) […]
Panel Spotlight | M&A Outlook: Expanding The Continuum Through New Services Lines Join us in the nation’s capital for a day of networking and thought leadership with industry executives in home health, private duty and hospice care. In this featured panel, you will hear how home health company valuations and deals have seen continued momentum in […]
After a down couple of months mirroring broader economic trends, home health stocks are headed back up. Home health stocks climbed by more than 21% in November compared to the previous month, according to the most recent Home Health Index (HHI) from Stoneridge Partners, a mergers-and-acquisitions firm based in Louisville, Kentucky. The HHI is a […]
HHCN’s Capital + Strategy Forum is NOT your typical industry conference — it is a catalyst for innovation in the changing home health care space. It brings together the brightest minds to share forward-looking ideas, inspirations and innovations in every aspect of home health, hospice, private duty and more. This is a first-class opportunity to network with thought leaders […]
While home health stocks rode M&A momentum and other tailwinds to an overall strong performance throughout much of 2018, the sustained boom period slowed down in September. Amid a broader market dip, that slowdown turned into an abrupt stop last month. Home health stocks fell more than 11% in October compared to their September standings, […]
Fueled by savvy moves from the United States’ two top independent and publicly traded home-based health care providers, home health stocks had seen strong month-after-month growth in 2018. Those hot growth levels now appear to be cooling off. Home health stocks were up just 0.74% in September compared to the previous month, according to the […]
Not much has shaken home health stocks so far in 2018 — not even the proposed Patient-Driven Groupings Model (PDGM) or the potential introduction of an updated pre-claim review initiative. Home health stocks appear to be continuing their upward march, according to the most recent update to Stoneridge Partners’ Home Health Index (HHI), updated monthly. […]